GlassScriptPhysician profile
Alex Aurelio Sanchez
NPI 1811164916
$4,730.72
in general payments reported to CMS, 2019-2025
37 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what 91% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $176 · 2022: $815 · 2023: $871 · 2024: $1,590 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,739.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $482.78 | 2022-2025 | Farxiga, Breztri, Lokelma |
| Otsuka America Pharmaceutical, INC. | $480.02 | 2022-2025 | Rexulti |
| Lilly USA, LLC | $433.24 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Vanda Pharmaceuticals INC. | $414.60 | 2024-2025 | Fanapt, Hetlioz |
| Novo Nordisk INC | $410.38 | 2022-2025 | Ozempic, Rybelsus, Tresiba |
| Teva Pharmaceuticals USA, INC. | $258.13 | 2022-2025 | Austedo Xr |
| Bayer Healthcare Pharmaceuticals INC. | $223.30 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $196.49 | 2022-2025 | |
| Abbott Laboratories | $174.74 | 2022-2024 | Eterna, Proclaim, Freestyle Libre 3 |
| Amgen INC. | $170.74 | 2024-2025 | Repatha, Repatha, Otezla |
| Boston Scientific Corporation | $146.57 | 2024 | Intracept |
| Angiodynamics, INC. | $126.29 | 2023 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $123.20 | 2021-2025 | |
| Inspire Medical Systems, INC. | $118.06 | 2024 | Inspire |
| Corium, LLC | $111.81 | 2023 | Adlarity |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.